UK Leads European Biobank Progress

Pharma IQ
Posted: 07/18/2010

The UK Biobank has smashed its initial target of filing the DNA of 500,000 adults aged 40-69, in what is seen as being the most comprehensive health study in the nation’s history.

The project, which has so far cost £65 million, will be keeping track of each individual’s medical profile in a long-term effort to understand the genetic, clinical and environmental factors that impact on overall health. It is hoped that in building this data, major advances can eventually be made in diagnosing and combating illnesses.
[inlinead]

Pharma IQ
Posted: 07/18/2010